Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06093464 · ClinicalTrials.gov registry record · NA

Beneficial Exposome Study

A NA study of Healthy, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06093464: Recruiting NA study of Healthy, sponsored by Stanford University.

NCT06093464 is a NA study of Healthy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06093464, a NA study of Healthy, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the positive, holistic health outcomes resulting from regular exposure to naturally occurring compounds predicted to have health benefits. The researchers hope to learn how the human body is influenced by regular exposure to these compounds.

Conditions Studied

Interventions

  • OTHER Natural Compound A (Hinoki essential oil)
  • OTHER Natural Compound B (Lemon essential oil)
  • OTHER Natural Compound C (Control/Water)

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-04-16
Est. Completion 2026-04
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06093464

The ClinicalTrials.gov registry entry for NCT06093464 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Natural Compound A (Hinoki essential oil) is the first listed.

NCT06093464 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06093464 about?

NCT06093464 is a clinical study titled "Beneficial Exposome Study". The purpose of this study is to explore the positive, holistic health outcomes resulting from regular exposure to naturally occurring compounds predicted to have health benefits. The researchers hope to learn how the human body is influenced by regular exposure to these compounds.

What is the current status of trial NCT06093464?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-04-16. Estimated completion is 2026-04.

What conditions does trial NCT06093464 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06093464?

The interventions under investigation include: Natural Compound A (Hinoki essential oil) (OTHER), Natural Compound B (Lemon essential oil) (OTHER), Natural Compound C (Control/Water) (OTHER).

Who is sponsoring clinical trial NCT06093464?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06093464 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.